SigmaWay Blog

SigmaWay Blog tries to aggregate original and third party content for the site users. It caters to articles on Process Improvement, Lean Six Sigma, Analytics, Market Intelligence, Training ,IT Services and industries which SigmaWay caters to

Application of Big Data Market Intelligence in Pharmaceutical companies


Consultants and pharmaceutical companies alike control the market intelligence channels to better understand their target patient population. Big Data offers a lot of opportunities to optimize commercial strategies from helping to identify opportunities for new therapies to assessing the success of current products. Surveyed companies are using Big Data initiatives to better target products or to assess the performance of products already on the market. Pharmacy companies are more likely to focus Big Data initiatives on current products, mainly on the success of drugs on the market. Many surveyed consultant companies use Big Data to assist in developing new therapies compared to the pharmaceutical companies. As data become more useful and the benefits more obvious, the prevalence of Big Data-driven market intelligence initiatives will continue to increase. A decision on regulations guiding social media marketing in particular also help companies decide which market intelligence strategies to attack. From the earliest to latest stages of drug marketing, companies are working quickly to discover the opportunities posed by Big Data. Read more at:

Rate this blog entry:
Market research reveals some facts about relocatin...
How to get great customers?

Related Posts



No comments made yet. Be the first to submit a comment
Already Registered? Login Here
Wednesday, 12 August 2020
If you'd like to register, please fill in the username, password and name fields.

Sigma Connect

sigmaway forums


Raise a question

Access Now

sigmaway blogs


Blog on cutting edge topics

Read More

sigmaway events


Hangout with us

Learn More

sigmaway newsletter


Start your subscription

Signup Now

Sign up for our newsletter

Follow us